The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lessons learned from a lung cancer screening patient navigation program at a safety-net hospital system.
 
Andrea R Semlow
No Relationships to Disclose
 
Vijaya Subbu Natchimuthu
No Relationships to Disclose
 
Simon Craddock Lee
No Relationships to Disclose
 
David E Gerber
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - BeiGene; Catalyst Pharmaceuticals; Janssen Oncology; Mirati Therapeutics; Regeneron; Samsung Bioepis; Sanofi
Research Funding - AstraZeneca (Inst); BerGenBio (Inst); Karyopharm Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending: “Prediction and Treatment of Immunotherapeutic Toxicity” (provisional, application number 62/461,455) (Inst); Royalties from Decision Support in Medicine from the Clinical Decision Support--Oncology on-line program.; Royalties from Oxford University Press from two books.
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb
 
Hong Zhu
No Relationships to Disclose
 
Heidi A. Hamann
No Relationships to Disclose
 
Travis Browning
No Relationships to Disclose
 
Noel O. Santini
No Relationships to Disclose
 
Jessica L. Lee
No Relationships to Disclose